Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
42,887,283
-
Shares change
-
+211,996
-
Total reported value, excl. options
-
$1,446,483,123
-
Value change
-
+$13,935,444
-
Put/Call ratio
-
78%
-
Number of buys
-
102
-
Number of sells
-
-66
-
Price
-
$33.73
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2018
211 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2018.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,887,283 shares
of 80,437,135 outstanding shares and own 53.32% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4,073,690 shares), BlackRock Inc. (3,452,161 shares), VANGUARD GROUP INC (3,197,129 shares), STATE STREET CORP (2,516,928 shares), D. E. Shaw & Co., Inc. (2,387,320 shares), SCOPIA CAPITAL MANAGEMENT LP (2,303,341 shares), venBio Select Advisor LLC (2,294,877 shares), BOXER CAPITAL, LLC (1,900,000 shares), Marshall Wace North America L.P. (1,709,974 shares), and GREAT POINT PARTNERS LLC (1,568,500 shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.